 |
FDA Approval Activities for this Drug
Amerge (Naratriptan hydrochloride) Tablets, 1 and 2.5 mg Glaxo Wellcome NDA 20-763 Amerge (Naratriptan) Tablets, GlaxoSmithKline NARATRIPTAN HYDROCHLORIDE Tablet; 1MG BASE AMERGE GLAXOSMITHKLINE 020763 NARATRIPTAN HYDROCHLORIDE Tablet; 2.5MG BASE AMERGE GLAXOSMITHKLINE | Naratriptan Tablets, Roxane Laboratories, Inc., Tentative Approval | Naratriptan Tablets, Sandoz Inc., Tentative Approval | Naratriptan (naratriptan hydrochloride)Tablets, Roxane Laboratories, Inc., Approval | Naratriptan (naratriptan hydrochloride) Tablets, Sandoz Inc., Approval | Naratriptan (naratriptan hydrochloride) Tablets, TEVA Pharmaceuticals, Approval | Amerge (naratriptan hydrochloride) Tablets, GlazoSmithKline, Approval | Naratriptan Tablets, Sun Pharmaceutical Industries, Ltd., Approval | Naratriptan Tablets, Indicus Pharma LLC, Approval | Naratriptan Tablets, Apotex Corp., Approval
^ FDA's latest approval appears at the bottom of this list. ^
|